Healthcare & Life Sciences
Kyverna Therapeutics
United Stateswww.kyverna.com
Kyverna Therapeutics is a Healthcare & Life Sciences startup based in the United States, most recent round Series B, 2 tracked investors.
Activeseries-b
series-b
Stage
2
Investors
About Kyverna Therapeutics
Based in the United States, Kyverna Therapeutics is a startup. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.
Kyverna Therapeutics is a clinical-stage biopharmaceutical company developing CAR T-cell therapies aimed at treating B cell-driven autoimmune diseases such as stiff person syndrome, multiple sclerosis, myasthenia gravis, systemic sclerosis, and lupus nephritis.
Explore Kyverna Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.